Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.

Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.

Item
http://www.wikidata.org/entity/Q40427213
Fibroblast growth factor signaling in skeletal development and diseaseA pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturationThe PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiation.New insight on FGFR3-related chondrodysplasias molecular physiopathology revealed by human chondrocyte gene expression profilingRecent research on the growth plate: Recent insights into the regulation of the growth plateEvaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasiaA novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia.Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models.Dephosphorylation of juxtamembrane serines and threonines of the NPR2 guanylyl cyclase is required for rapid resumption of oocyte meiosis in response to luteinizing hormone.Role of FGFs/FGFRs in skeletal development and bone regeneration.Advances in treatment of achondroplasia and osteoarthritis.Achondroplasia: Development, pathogenesis, and therapy.C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways.Molecular therapeutic strategies for FGFR3 gene-related skeletal dysplasia.Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor.Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature.
P2860

Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.

Item
http://www.wikidata.org/entity/Q40427213
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Complementary antagonistic act ...... through FGFR-3 in ATDC5 cells.
@en
type
label
Complementary antagonistic act ...... through FGFR-3 in ATDC5 cells.
@en
prefLabel
Complementary antagonistic act ...... through FGFR-3 in ATDC5 cells.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Complementary antagonistic act ...... through FGFR-3 in ATDC5 cells.
@en
P2093
P304
P31
P356
10.1016/J.BONE.2005.03.006
P433
P478
P577
P5875
P698
P921